Metastatic cancer

Common Name(s)

Metastatic cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic cancer" returned 3410 free, full-text research articles on human participants. First 3 results:

Enzalutamide in metastatic prostate cancer before chemotherapy.
 

Author(s): Tomasz M Beer, Bertrand Tombal

Journal: N. Engl. J. Med.. 2014 Oct;371(18):1755-6.

 

Last Updated: 30 Oct 2014

Go To URL
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
 

Author(s): Ben Van Calster, Kirsten Van Hoorde, Lil Valentin, Antonia C Testa, Daniela Fischerova, Caroline Van Holsbeke, Luca Savelli, Dorella Franchi, Elisabeth Epstein, Jeroen Kaijser, Vanya Van Belle, Artur Czekierdowski, Stefano Guerriero, Robert Fruscio, Chiara Lanzani, Felice Scala, Tom Bourne, Dirk Timmerman,

Journal:

 

To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.

Last Updated: 16 Oct 2014

Go To URL
Cost-effectiveness analysis of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer.
 

Author(s): Christopher N Graham, Guy Hechmati, Jonas Hjelmgren, Frédérique de Liège, Julie Lanier, Hediyyih Knox, Beth Barber

Journal: Eur. J. Cancer. 2014 Nov;50(16):2791-801.

 

To investigate the cost-effectiveness of panitumumab plus mFOLFOX6 (oxaliplatin, 5-fluorouracil and leucovorin) compared with bevacizumab plus mFOLFOX6 in first-line treatment of patients with wild-type RAS metastatic colorectal cancer (mCRC).

Last Updated: 10 Oct 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic cancer" returned 338 free, full-text review articles on human participants. First 3 results:

Using nuclear medicine imaging in clinical practice: update on PET to guide treatment of patients with metastatic breast cancer.
 

Author(s): Amy S Clark, Elizabeth McDonald, M Camilla Lynch, David Mankoff

Journal: Oncology (Williston Park, N.Y.). 2014 May;28(5):424-30.

 

As we enter the era of personalized medicine, tests that can inform on molecular mechanisms of cancer, and on breast cancer in particular, are in high demand. We currently use DNA- or RNA-based tests of gene expression and/or immunohistochemistry to better characterize a given breast ...

Last Updated: 9 Jul 2014

Go To URL
Colorectal cancer: prevention and management of metastatic disease.
 

Author(s): Paul H Sugarbaker

Journal: Biomed Res Int. 2014 ;2014():782890.

 

This paper compared the similarities and differences of the two most common types of colorectal cancer metastases. The treatment of liver metastases by surgery combined with systemic chemotherapy was explained. The different natural history of liver metastases as compared to peritoneal ...

Last Updated: 30 Apr 2014

Go To URL
Radium-223 in metastatic castration resistant prostate cancer.
 

Author(s): Winston Vuong, Oliver Sartor, Sumanta K Pal

Journal: Asian J. Androl.. ;16(3):348-53.

 

In 2004, docetaxel was approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). For the next several years, there was a lull in drug approvals. However, from 2010 onwards, 5 additional therapies have been approved on the basis of showing a survival benefit ...

Last Updated: 6 May 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 26 Sep 2014

Go to URL
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Metastatic Melanoma; Renal Cancer; Colorectal Cancer; Ovarian Cancer; Lung Cancer

 

Last Updated: 5 Dec 2014

Go to URL
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
 

Status: Recruiting

Condition Summary: Advanced Cancer; Metastatic Cancer; Solid Tumors

 

Last Updated: 9 Sep 2013

Go to URL